Terug
Dagbereik
€ 13,68
€ 14,10
52-Weeksbereik
€ 12,12
€ 35,34
Volume
1.244.051
50D / 200D Gem.
€ 13,73
/
€ 21,21
Vorige Slotkoers
€ 13,56
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,4 | 0,3 |
| P/B | 0,9 | 3,0 |
| ROE % | -11,5 | 3,7 |
| Net Margin % | -1136,3 | 3,8 |
| Rev Growth 5Y % | 28,8 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 39,80
+188.4%
Low: € 29,00
High: € 57,00
Forward WPA
-€ 2,66
Omzet Sch.
10,13M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 2,82
-€ 2,82 – -€ 2,82
|
232,85M | 5 |
| FY2029 |
-€ 3,49
-€ 3,49 – -€ 3,49
|
111,57M | 10 |
| FY2028 |
-€ 3,67
-€ 5,74 – -€ 2,54
|
39,03M | 12 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | -€ 0,62 | -€ 0,51 | +18,4% |
| 2025-11-06 | -€ 0,60 | -€ 0,39 | +35,0% |
| 2025-08-07 | -€ 0,48 | -€ 0,55 | -14,6% |
| 2025-05-08 | -€ 0,43 | -€ 0,38 | +11,6% |
| 2025-02-27 | -€ 0,49 | -€ 0,36 | +26,5% |
| 2024-11-06 | -€ 0,37 | -€ 0,51 | -37,8% |
| 2024-08-07 | -€ 0,32 | -€ 0,11 | +65,6% |
| 2024-05-07 | -€ 0,35 | -€ 0,30 | +14,3% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 28,77% annually over 5 years — strong growth
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -83,28M
Revenue growth is decelerating — 1Y growth trails 5Y average by 34,32%
Groei
Revenue Growth (5Y)
28,77%
Revenue (1Y)-5,55%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-11,48%
ROIC-12,08%
Net Margin-1136,25%
Op. Margin-1576,67%
Veiligheid
Debt / Equity
0,02
Current Ratio39,04
Interest Coverage0,00
Waardering
P/E Ratio
-7,39
Forward P/EN/A
P/B Ratio0,88
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5,55% | Revenue Growth (3Y) | 11,23% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 28,77% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 10,00M | Net Income (TTM) | -113,63M |
| ROE | -11,48% | ROA | -11,34% |
| Gross Margin | 79,71% | Operating Margin | -1576,67% |
| Net Margin | -1136,25% | Free Cash Flow (TTM) | -83,28M |
| ROIC | -12,08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 39,04 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7,39 | Forward P/E | N/A |
| P/B Ratio | 0,88 | P/S Ratio | 83,95 |
| PEG Ratio | -0,18 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 82,91 | Fwd Earnings Yield | N/A |
| FCF Yield | -9,92% | ||
| Market Cap | 839,48M | Enterprise Value | 809,28M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 10,00M | 10,59M | 8,08M | 8,61M | 3,64M |
| Net Income | -113,63M | -68,99M | -58,29M | -63,06M | -32,67M |
| EPS (Diluted) | -1,83 | -1,28 | -1,32 | -1,52 | -0,79 |
| Gross Profit | 7,97M | 8,53M | 6,13M | 7,77M | 3,64M |
| Operating Income | -157,67M | -98,85M | -72,98M | -67,09M | -32,93M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,00B | 1,06B | 380,41M | 364,01M | 379,82M |
| Total Liabilities | 44,74M | 38,74M | 36,06M | 43,27M | 13,50M |
| Shareholders' Equity | 956,82M | 1,02B | 344,35M | 320,74M | 366,33M |
| Total Debt | 22,14M | 23,03M | 24,54M | 25,31M | 194.000,0 |
| Cash & Equivalents | 52,33M | 430,61M | 19,21M | 51,43M | 35,58M |
| Current Assets | 975,89M | 1,03B | 349,24M | 332,44M | 377,02M |
| Current Liabilities | 25,00M | 17,46M | 13,03M | 16,51M | 12,80M |